PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
26.36%
Revenue growth 1.25-1.5x CRWV's 23.55%. Bruce Berkowitz would examine if growth advantage is sustainable.
74.66%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
18.22%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-6.45%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
3.06%
R&D change of 3.06% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.11%
Operating expenses growth above 1.5x CRWV's 17.97%. Michael Burry would check for inefficiency.
51.75%
Total costs growth above 1.5x CRWV's 18.28%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
4.61%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-1.35%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-48.48%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-1.93%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-22.39%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
151.09%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
77.90%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
40.79%
Pre-tax margin growth exceeding 1.5x CRWV's 26.86%. David Dodd would verify competitive advantages.
77.81%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
77.94%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
40.82%
Net margin growth exceeding 1.5x CRWV's 25.27%. David Dodd would verify competitive advantages.
75.00%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
75.00%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
-0.06%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.20%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.